Annual Operating Profit
-$133.43 M
+$134.15 M+50.13%
31 December 2023
Summary:
Inovio Pharmaceuticals annual operaing income is currently -$133.43 million, with the most recent change of +$134.15 million (+50.13%) on 31 December 2023. During the last 3 years, it has fallen by -$9.34 million (-7.53%). INO annual operating profit is now -2421.10% below its all-time high of -$5.29 million, reached on 01 March 2001.INO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$27.35 M
+$5.85 M+17.62%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly operating income is currently -$27.35 million, with the most recent change of +$5.85 million (+17.62%) on 30 September 2024. Over the past year, it has dropped by -$2.31 million (-9.22%). INO quarterly operating profit is now -833.10% below its all-time high of $3.73 million, reached on 30 September 2015.INO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$119.42 M
-$2.31 M-1.97%
30 September 2024
Summary:
Inovio Pharmaceuticals TTM operating income is currently -$119.42 million, with the most recent change of -$2.31 million (-1.97%) on 30 September 2024. Over the past year, it has increased by +$42.56 million (+26.27%). INO TTM operating profit is now -6614.07% below its all-time high of -$1.78 million, reached on 31 March 1999.INO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.1% | -9.2% | +26.3% |
| 3 y3 years | -7.5% | +54.4% | +46.9% |
| 5 y5 years | -41.8% | -14.2% | -8.4% |
INO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.5% | +55.7% | -9.2% | +74.1% | -2.0% | +65.0% |
| 5 y | 5 years | -41.8% | +55.7% | -14.2% | +74.1% | -10.8% | +65.0% |
| alltime | all time | -2421.1% | +55.7% | -833.1% | +74.1% | -6614.1% | +65.0% |
Inovio Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$27.35 M(-17.6%) | -$119.42 M(+2.0%) |
| June 2024 | - | -$33.20 M(+5.4%) | -$117.12 M(-3.2%) |
| Mar 2024 | - | -$31.48 M(+14.9%) | -$120.96 M(-9.3%) |
| Dec 2023 | -$133.43 M(-50.1%) | -$27.39 M(+9.4%) | -$133.43 M(-17.6%) |
| Sept 2023 | - | -$25.04 M(-32.4%) | -$161.98 M(-6.2%) |
| June 2023 | - | -$37.04 M(-15.7%) | -$172.70 M(-28.0%) |
| Mar 2023 | - | -$43.95 M(-21.4%) | -$239.79 M(-10.4%) |
| Dec 2022 | -$267.57 M(-11.2%) | -$55.95 M(+56.5%) | -$267.57 M(-15.6%) |
| Sept 2022 | - | -$35.76 M(-65.7%) | -$317.14 M(-7.1%) |
| June 2022 | - | -$104.14 M(+45.2%) | -$341.33 M(+6.5%) |
| Mar 2022 | - | -$71.73 M(-32.0%) | -$320.40 M(+6.4%) |
| Dec 2021 | -$301.22 M(+142.8%) | -$105.51 M(+76.0%) | -$301.22 M(+33.8%) |
| Sept 2021 | - | -$59.95 M(-27.9%) | -$225.05 M(+11.7%) |
| June 2021 | - | -$83.20 M(+58.3%) | -$201.43 M(+33.0%) |
| Mar 2021 | - | -$52.55 M(+79.1%) | -$151.40 M(+22.0%) |
| Dec 2020 | -$124.08 M(+11.7%) | -$29.34 M(-19.2%) | -$124.08 M(-0.9%) |
| Sept 2020 | - | -$36.33 M(+9.5%) | -$125.16 M(+11.0%) |
| June 2020 | - | -$33.18 M(+31.5%) | -$112.79 M(+4.6%) |
| Mar 2020 | - | -$25.23 M(-17.1%) | -$107.81 M(-3.0%) |
| Dec 2019 | -$111.11 M(+18.1%) | -$30.42 M(+27.0%) | -$111.11 M(+0.8%) |
| Sept 2019 | - | -$23.95 M(-15.1%) | -$110.19 M(-2.4%) |
| June 2019 | - | -$28.20 M(-1.2%) | -$112.88 M(+25.6%) |
| Mar 2019 | - | -$28.54 M(-3.3%) | -$89.88 M(-4.5%) |
| Dec 2018 | -$94.09 M(+11.2%) | -$29.50 M(+10.7%) | -$94.09 M(+6.3%) |
| Sept 2018 | - | -$26.64 M(+412.0%) | -$88.48 M(-2.8%) |
| June 2018 | - | -$5.20 M(-84.1%) | -$91.02 M(-4.6%) |
| Mar 2018 | - | -$32.75 M(+37.1%) | -$95.46 M(+12.8%) |
| Dec 2017 | -$84.64 M(+9.6%) | -$23.89 M(-18.2%) | -$84.64 M(+1.8%) |
| Sept 2017 | - | -$29.19 M(+202.9%) | -$83.12 M(+12.1%) |
| June 2017 | - | -$9.64 M(-56.1%) | -$74.13 M(-11.5%) |
| Mar 2017 | - | -$21.93 M(-1.9%) | -$83.72 M(+8.4%) |
| Dec 2016 | -$77.24 M(+118.9%) | -$22.36 M(+10.7%) | -$77.24 M(+11.3%) |
| Sept 2016 | - | -$20.20 M(+5.0%) | -$69.40 M(+52.6%) |
| June 2016 | - | -$19.23 M(+24.4%) | -$45.47 M(+7.3%) |
| Mar 2016 | - | -$15.45 M(+6.4%) | -$42.37 M(+20.1%) |
| Dec 2015 | -$35.28 M(-10.7%) | -$14.53 M(-489.4%) | -$35.28 M(+11.1%) |
| Sept 2015 | - | $3.73 M(-123.1%) | -$31.77 M(-27.5%) |
| June 2015 | - | -$16.12 M(+92.6%) | -$43.83 M(+15.8%) |
| Mar 2015 | - | -$8.37 M(-24.0%) | -$37.86 M(-4.1%) |
| Dec 2014 | -$39.50 M(+83.3%) | -$11.01 M(+32.2%) | -$39.50 M(+5.4%) |
| Sept 2014 | - | -$8.33 M(-17.9%) | -$37.49 M(+32.0%) |
| June 2014 | - | -$10.15 M(+1.5%) | -$28.39 M(+14.0%) |
| Mar 2014 | - | -$10.00 M(+11.1%) | -$24.91 M(+15.6%) |
| Dec 2013 | -$21.54 M(-12.6%) | -$9.00 M(-1276.1%) | -$21.54 M(+14.8%) |
| Sept 2013 | - | $765.60 K(-111.5%) | -$18.77 M(-28.7%) |
| June 2013 | - | -$6.67 M(+0.6%) | -$26.33 M(-0.4%) |
| Mar 2013 | - | -$6.63 M(+6.5%) | -$26.44 M(+7.3%) |
| Dec 2012 | -$24.64 M(+10.9%) | -$6.23 M(-8.3%) | -$24.64 M(+1.8%) |
| Sept 2012 | - | -$6.79 M(+0.1%) | -$24.20 M(+0.5%) |
| June 2012 | - | -$6.79 M(+40.3%) | -$24.08 M(+7.4%) |
| Mar 2012 | - | -$4.84 M(-16.3%) | -$22.43 M(+0.9%) |
| Dec 2011 | -$22.23 M | -$5.78 M(-13.4%) | -$22.23 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$6.67 M(+29.9%) | -$21.73 M(+10.8%) |
| June 2011 | - | -$5.14 M(+10.8%) | -$19.61 M(+0.8%) |
| Mar 2011 | - | -$4.64 M(-12.2%) | -$19.45 M(+1.2%) |
| Dec 2010 | -$19.22 M(+37.7%) | -$5.28 M(+15.9%) | -$19.22 M(+8.3%) |
| Sept 2010 | - | -$4.56 M(-8.4%) | -$17.75 M(+5.7%) |
| June 2010 | - | -$4.98 M(+12.9%) | -$16.79 M(+13.4%) |
| Mar 2010 | - | -$4.41 M(+15.7%) | -$14.80 M(+6.1%) |
| Dec 2009 | -$13.96 M(+2.2%) | -$3.81 M(+6.0%) | -$13.96 M(+2.6%) |
| Sept 2009 | - | -$3.60 M(+20.3%) | -$13.61 M(+6.6%) |
| June 2009 | - | -$2.99 M(-16.0%) | -$12.76 M(-8.0%) |
| Mar 2009 | - | -$3.56 M(+2.9%) | -$13.87 M(+1.6%) |
| Dec 2008 | -$13.66 M(-14.1%) | -$3.46 M(+25.9%) | -$13.66 M(+13.7%) |
| Sept 2008 | - | -$2.75 M(-33.0%) | -$12.01 M(-15.9%) |
| June 2008 | - | -$4.10 M(+22.6%) | -$14.29 M(-4.4%) |
| Mar 2008 | - | -$3.35 M(+84.7%) | -$14.94 M(-6.0%) |
| Dec 2007 | -$15.90 M(+19.1%) | -$1.81 M(-64.0%) | -$15.90 M(-11.1%) |
| Sept 2007 | - | -$5.03 M(+5.7%) | -$17.88 M(+9.1%) |
| June 2007 | - | -$4.76 M(+10.5%) | -$16.39 M(+10.5%) |
| Mar 2007 | - | -$4.30 M(+13.4%) | -$14.84 M(+11.2%) |
| Dec 2006 | -$13.35 M(+9.6%) | -$3.79 M(+7.3%) | -$13.35 M(+5.8%) |
| Sept 2006 | - | -$3.54 M(+10.4%) | -$12.62 M(+4.2%) |
| June 2006 | - | -$3.20 M(+13.9%) | -$12.12 M(+9.2%) |
| Mar 2006 | - | -$2.81 M(-8.3%) | -$11.10 M(-8.8%) |
| Dec 2005 | -$12.18 M(+5.8%) | -$3.07 M(+1.1%) | -$12.17 M(-6.3%) |
| Sept 2005 | - | -$3.03 M(+38.8%) | -$12.99 M(-3.8%) |
| June 2005 | - | -$2.19 M(-43.8%) | -$13.50 M(-2.0%) |
| Mar 2005 | - | -$3.89 M(+0.0%) | -$13.78 M(+19.7%) |
| Dec 2004 | -$11.51 M(+73.5%) | -$3.89 M(+9.7%) | -$11.51 M(+22.0%) |
| Sept 2004 | - | -$3.54 M(+43.7%) | -$9.43 M(+24.3%) |
| June 2004 | - | -$2.47 M(+52.5%) | -$7.59 M(+16.3%) |
| Mar 2004 | - | -$1.62 M(-10.6%) | -$6.52 M(-1.9%) |
| Dec 2003 | -$6.63 M(+11.8%) | -$1.81 M(+6.5%) | -$6.65 M(+5.8%) |
| Sept 2003 | - | -$1.70 M(+21.3%) | -$6.28 M(+3.7%) |
| June 2003 | - | -$1.40 M(-19.8%) | -$6.06 M(-2.0%) |
| Mar 2003 | - | -$1.75 M(+21.0%) | -$6.18 M(+4.2%) |
| Dec 2002 | -$5.93 M(-0.1%) | -$1.44 M(-2.0%) | -$5.93 M(+32.1%) |
| Sept 2002 | - | -$1.47 M(-3.3%) | -$4.49 M(-5.0%) |
| June 2002 | - | -$1.52 M(+2.0%) | -$4.72 M(-20.5%) |
| Mar 2002 | - | -$1.49 M(-12.6%) | -$5.94 M(+5.8%) |
| Dec 2001 | -$5.94 M(+12.2%) | - | - |
| Sept 2001 | - | -$1.71 M(-37.6%) | -$5.61 M(-5.6%) |
| June 2001 | - | -$2.74 M(-348.9%) | -$5.95 M(+12.4%) |
| Mar 2001 | - | $1.10 M(-148.5%) | -$5.29 M(-40.7%) |
| Mar 2001 | -$5.29 M(-44.5%) | - | - |
| Dec 2000 | - | -$2.27 M(+11.0%) | -$8.93 M(+4.3%) |
| Sept 2000 | - | -$2.04 M(-1.8%) | -$8.56 M(+0.5%) |
| June 2000 | - | -$2.08 M(-17.9%) | -$8.52 M(-9.7%) |
| Mar 2000 | -$9.53 M(+38.6%) | -$2.53 M(+33.4%) | -$9.43 M(+72.2%) |
| Dec 1999 | - | -$1.90 M(-5.0%) | -$5.48 M(-19.2%) |
| Sept 1999 | - | -$2.00 M(-33.3%) | -$6.78 M(+41.9%) |
| June 1999 | - | -$3.00 M(-311.1%) | -$4.78 M(+168.7%) |
| Mar 1999 | -$6.88 M | $1.42 M(-144.4%) | -$1.78 M(-44.4%) |
| Dec 1998 | - | -$3.20 M | -$3.20 M |
FAQ
- What is Inovio Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual operating profit year-on-year change?
- What is Inovio Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly operating profit year-on-year change?
- What is Inovio Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals TTM operating profit year-on-year change?
What is Inovio Pharmaceuticals annual operaing income?
The current annual operating profit of INO is -$133.43 M
What is the all time high annual operating profit for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual operaing income is -$5.29 M
What is Inovio Pharmaceuticals annual operating profit year-on-year change?
Over the past year, INO annual operaing income has changed by +$134.15 M (+50.13%)
What is Inovio Pharmaceuticals quarterly operating income?
The current quarterly operating profit of INO is -$27.35 M
What is the all time high quarterly operating profit for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly operating income is $3.73 M
What is Inovio Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, INO quarterly operating income has changed by -$2.31 M (-9.22%)
What is Inovio Pharmaceuticals TTM operating income?
The current TTM operating profit of INO is -$119.42 M
What is the all time high TTM operating profit for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high TTM operating income is -$1.78 M
What is Inovio Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, INO TTM operating income has changed by +$42.56 M (+26.27%)